Medicare Enrolled
Dr. Zaven Arslanian, M.D.
Dermatology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Arslanian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arslanian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arslanian
Dr. Zaven Arslanian is a dermatology specialist in Glendale, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Arslanian performed 8,221 Medicare services across 2,123 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arslanian received a total of $31,019 from 100 pharmaceutical and/or device companies across 1584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arslanian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in CA
$31,019 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,221
Medicare services
Top 6% in CA for dermatology
2,123
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~433 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
6,375 | $75 | $120 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
707 | $8 | $15 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
343 | $3 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
315 | $68 | $125 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
210 | $45 | $135 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
64 | $13 | $65 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
44 | $70 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $149 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
36 | $117 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $69 | $154 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $109 | $175 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
13 | $144 | $250 |
| Annual alcohol misuse screening, 5 to 15 minutes | 13 | $21 | $35 |
| Annual depression screening | 12 | $21 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$31,019
Total received (2018-2024)
Avg $4,431/year across 7 years
Top 1% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
100
Companies
1,584
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,840 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$179 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,640
2023
$4,193
2022
$3,958
2021
$4,908
2020
$4,204
2019
$5,183
2018
$4,934
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$509
Amgen Inc.
$393
AstraZeneca Pharmaceuticals LP
$321
Boehringer Ingelheim Pharmaceuticals, Inc.
$296
Novo Nordisk Inc
$204
Ardelyx, Inc.
$157
Esperion Therapeutics, Inc.
$151
Lilly USA, LLC
$151
GlaxoSmithKline, LLC.
$147
Sumitomo Pharma America, Inc.
$138
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$136
AIMMUNE THERAPEUTICS, INC.
$115
Almatica Pharma LLC
$115
IRONWOOD PHARMACEUTICALS, INC
$102
Otsuka America Pharmaceutical, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$85
RedHill Biopharma Inc.
$75
Lundbeck LLC
$70
Merck Sharp & Dohme LLC
$68
VIVUS LLC
$56
IDORSIA PHARMACEUTICALS US INC
$49
Gilead Sciences, Inc.
$34
Hikma Pharmaceuticals USA
$24
Novartis Pharmaceuticals Corporation
$23
SHIELD THERAPEUTICS INC
$22
Kowa Pharmaceuticals America, Inc.
$20
Phathom Pharmaceuticals, Inc.
$18
Dexcom, Inc.
$17
Mylan Specialty L.P.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$14
Azurity Pharmaceuticals, Inc.
$14
PFIZER INC.
$14
Top 3 companies account for 33.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,669
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,643
Amarin Pharma Inc.
$2,346
Amgen Inc.
$1,719
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,587
Novo Nordisk Inc
$1,437
AbbVie Inc.
$1,305
Esperion Therapeutics, Inc.
$1,107
Takeda Pharmaceuticals U.S.A., Inc.
$987
ABBVIE INC.
$980
Lilly USA, LLC
$915
SANOFI-AVENTIS U.S. LLC
$872
GlaxoSmithKline, LLC.
$715
Astellas Pharma US Inc
$714
Novartis Pharmaceuticals Corporation
$633
Horizon Therapeutics plc
$578
Avanir Pharmaceuticals, Inc.
$480
Ironwood Pharmaceuticals, Inc
$462
Synergy Pharmaceuticals Inc
$450
PFIZER INC.
$438
Janssen Pharmaceuticals, Inc
$333
AbbVie, Inc.
$330
Allergan Inc.
$310
Bayer Healthcare Pharmaceuticals Inc.
$306
Allergan, Inc.
$304
Hikma Pharmaceuticals USA
$290
Merck Sharp & Dohme Corporation
$286
RedHill Biopharma Inc.
$278
Sumitomo Pharma America, Inc.
$266
Merck Sharp & Dohme LLC
$224
IRONWOOD PHARMACEUTICALS, INC
$221
Almatica Pharma LLC
$214
Lundbeck LLC
$210
Gilead Sciences, Inc.
$193
Bayer HealthCare Pharmaceuticals Inc.
$192
Acorda Therapeutics, Inc
$179
Scilex Pharmaceuticals Inc.
$175
Bausch Health US, LLC
$172
Eisai Inc.
$171
Adamas Pharmaceuticals, Inc.
$167
Ardelyx, Inc.
$157
ASCEND Therapeutics US, LLC
$144
IBSA Pharma Inc.
$144
Kowa Pharmaceuticals America, Inc.
$136
Radius Health, Inc.
$124
Biohaven Pharmaceuticals, Inc.
$121
AIMMUNE THERAPEUTICS, INC.
$115
IDORSIA PHARMACEUTICALS US INC
$115
Nestle HealthCare Nutrition Inc.
$111
Otsuka America Pharmaceutical, Inc.
$106
Mylan Specialty L.P.
$94
Biohaven Pharmaceutical Holding Company Ltd.
$90
Corium, LLC
$87
ARBOR PHARMACEUTICALS, INC.
$80
Sunovion Pharmaceuticals Inc.
$80
VIVUS LLC
$76
Teva Pharmaceuticals USA, Inc.
$68
Xeris Pharmaceuticals, Inc.
$58
GENZYME CORPORATION
$58
Genentech USA, Inc.
$55
Amneal Pharmaceuticals LLC
$50
Regeneron Healthcare Solutions, Inc.
$49
ACADIA Pharmaceuticals Inc
$49
NESTLE HEALTHCARE NUTRITION INC.
$48
Arbor Pharmaceuticals, Inc.
$46
ITI, Inc.
$44
Ferring Pharmaceuticals Inc.
$42
Valeritas, Inc.
$42
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
LEO Pharma Inc.
$39
Concordia Pharmaceuticals Inc.
$36
Phathom Pharmaceuticals, Inc.
$36
Shield Therapeutics Inc
$35
Eyevance Pharmaceuticals LLC
$35
OptiNose US, Inc.
$33
Azurity Pharmaceuticals, Inc.
$32
Tactile Systems Technology Inc
$30
UROVANT SCIENCES INC
$30
Zyla Life Sciences
$28
TerSera Therapeutics LLC
$25
Promius Pharma LLC
$24
Biogen, Inc.
$23
Sun Pharmaceutical Industries Inc.
$23
SHIELD THERAPEUTICS INC
$22
EVOKE PHARMA, INC.
$22
Egalet US Inc
$20
Alfasigma USA, Inc.
$20
MDD US Operations, LLC
$20
Evoke Pharma, Inc.
$19
Horizon Pharma plc
$19
Avion Pharmaceuticals
$19
Circassia Pharmaceuticals Inc
$17
Dexcom, Inc.
$17
Smith & Nephew, Inc.
$17
West-Ward Pharmaceuticals
$16
Avadel Specialty Pharmaceuticals, LLC
$15
Collegium Pharmaceutical, Inc.
$15
Ethicon US, LLC
$15
Lupin Inc.
$14
Medicure Pharma Inc.
$14
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADLARITY · ADUHELM · AIRSUPRA · AJOVY · AMYVID · ANORO · APLENZIN · APRISO · Adlarity · Aemcolo · Aimovig · Amitiza · BAQSIMI · BASAGLAR · BELSOMRA · BINOSTO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · Balcoltra · CAPLYTA · CHANTIX · CIBINQO · COLOGUARD DNA CAPTURE REAGENTS · CREON · Creon · DUAKLIR PRESSAIR · DUEXIS · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · Donnatal · ELYXYB - celecoxib · EMGALITY · ENSTILAR · ENTRESTO · ESTROGEL · EUCRISA · EUFLEXXA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLEXITOUCH · Flexitouch Plus · GEMTESA · GIMOTI · GOCOVRI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HORIZANT · Horizant · IBSRELA · INBRIJA · INVOKANA · JANUMET · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · LEQVIO · LICART · LINX Reflux Management System · LINZESS · LOREEV XR · LYRICA · LYUMJEV · Licart · Linzess · Livalo · MIGRANAL · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Mitigare · Motegrity · Movantik · Myrbetriq · NEXLETOL · NEXLIZET · NUEDEXTA · NUPLAZID · NURTEC ODT · Noctiva · Nuedexta · Otezla · Ozempic · PANCREAZE · PAZEO · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · Prolia · QMIIZ ODT · QULIPTA · QUVIVIQ · QVAR · RAYOS · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · RYTARY · Repatha · Ryaltris · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SPIRIVA RESPIMAT · SPRIX · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Santyl · Synthroid · TERIPARATIDE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Talicia · Tirosint · Tobradex ST · Trintellix · Trulance · Tymlos · UBRELVY · UPLIZNA · UTIBRON · V-GO · VERQUVO · VIBERZI · VIMOVO · VOQUEZNA · VRAYLAR · Vascepa · Veklury · Veozah · WELLBUTRIN XL · XADAGO · XARELTO · XIFAXAN · XIFAXANIBSD · XIIDRA · Xhance · Xofluza · YUPELRI · ZENPEP · ZORVOLEX · ZORYVE · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · ZYPITAMAG · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for dermatology in CA.
Geographic Context
Dermatologists within 10 mi
545
Per 100K population
5.5
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Arslanian is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Arslanian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Arslanian performed 6,375 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arslanian receive payments from pharmaceutical companies?
Yes. Dr. Arslanian received a total of $31,019 from 100 companies across 1,584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arslanian's costs compare to other dermatologists in Glendale?
Dr. Arslanian's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arslanian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Glendale
Browse dermatologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology